Search research articles
Contact Us
Filters
Showing results (101-110 of 297) with videos related to
Page
of 30
Sort By:
BMJ Open
|
September 13, 2019
Risk factors for further sick leave among Japanese workers returning to work after an episode of major depressive disorder: a prospective follow-up study over 1 year
Hikaru Hori, Asuka Katsuki, Kiyokazu Atake, et al.
Journal of Psychiatric Research
|
September 24, 2013
Switching to antipsychotic monotherapy can improve attention and processing speed, and social activity in chronic schizophrenia patients
Hikaru Hori, Reiji Yoshimura, Asuka Katsuki, et al.
Immunogenetics
|
September 23, 2017
Immunoglobulin genotypes and cognitive functions in schizophrenia
Janardan P Pandey, Aryan M Namboodiri, Paul J Nietert, et al.
Frontiers in Rehabilitation Sciences
|
March 27, 2023
Estimation of subjective quality of life in schizophrenic patients using speech features
Yuko Shibata, John Noel Victorino, Tomoya Natsuyama, et al.
Biochemical Pharmacology
|
September 13, 2005
Effect of prolonged exposure to milnacipran on norepinephrine transporter in cultured bovine adrenal medullary cells
Koji Shinkai, Reiji Yoshimura, Yumiko Toyohira, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry
|
July 14, 2016
Relationships between serum brain-derived neurotrophic factor, plasma catecholamine metabolites, cytokines, cognitive function and clinical symptoms in Japanese patients with chronic schizophrenia treated with atypical antipsychotic monotherapy
Hikaru Hori, Reiji Yoshimura, Asuka Katsuki, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
April 1, 2009
Higher plasma interleukin-6 (IL-6) level is associated with SSRI- or SNRI-refractory depression
Reiji Yoshimura, Hikaru Hori, Atsuko Ikenouchi-Sugita, et al.
BMC Psychiatry
|
April 9, 2014
Study protocol: safety correction of high dose antipsychotic polypharmacy in Japan
Tsuruhei Sukegawa, Ataru Inagaki, Yoshio Yamanouchi, et al.
Frontiers in Psychiatry
|
March 21, 2024
Fronto-striato network function is reduced in major depressive disorder
Reoto Kijima, Keita Watanabe, Naomichi Okamoto, et al.
Neuropsychiatric Disease and Treatment
|
April 2, 2009
Continuous decrease in serum brain-derived neurotrophic factor (BDNF) levels in a neuropsychiatric syndrome of systemic lupus erythematosus patient with organic brain changes
Atsuko Ikenouchi-Sugita, Reiji Yoshimura, Nobuhisa Ueda, et al.
Page
of 30
Search research articles
Search
Showing results (101-110 of 297) with videos related to
Sort By:
Page
of 30
BMJ Open
|
September 13, 2019
Risk factors for further sick leave among Japanese workers returning to work after an episode of major depressive disorder: a prospective follow-up study over 1 year
Hikaru Hori, Asuka Katsuki, Kiyokazu Atake, et al.
Journal of Psychiatric Research
|
September 24, 2013
Switching to antipsychotic monotherapy can improve attention and processing speed, and social activity in chronic schizophrenia patients
Hikaru Hori, Reiji Yoshimura, Asuka Katsuki, et al.
Immunogenetics
|
September 23, 2017
Immunoglobulin genotypes and cognitive functions in schizophrenia
Janardan P Pandey, Aryan M Namboodiri, Paul J Nietert, et al.
Frontiers in Rehabilitation Sciences
|
March 27, 2023
Estimation of subjective quality of life in schizophrenic patients using speech features
Yuko Shibata, John Noel Victorino, Tomoya Natsuyama, et al.
Biochemical Pharmacology
|
September 13, 2005
Effect of prolonged exposure to milnacipran on norepinephrine transporter in cultured bovine adrenal medullary cells
Koji Shinkai, Reiji Yoshimura, Yumiko Toyohira, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry
|
July 14, 2016
Relationships between serum brain-derived neurotrophic factor, plasma catecholamine metabolites, cytokines, cognitive function and clinical symptoms in Japanese patients with chronic schizophrenia treated with atypical antipsychotic monotherapy
Hikaru Hori, Reiji Yoshimura, Asuka Katsuki, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
April 1, 2009
Higher plasma interleukin-6 (IL-6) level is associated with SSRI- or SNRI-refractory depression
Reiji Yoshimura, Hikaru Hori, Atsuko Ikenouchi-Sugita, et al.
BMC Psychiatry
|
April 9, 2014
Study protocol: safety correction of high dose antipsychotic polypharmacy in Japan
Tsuruhei Sukegawa, Ataru Inagaki, Yoshio Yamanouchi, et al.
Frontiers in Psychiatry
|
March 21, 2024
Fronto-striato network function is reduced in major depressive disorder
Reoto Kijima, Keita Watanabe, Naomichi Okamoto, et al.
Neuropsychiatric Disease and Treatment
|
April 2, 2009
Continuous decrease in serum brain-derived neurotrophic factor (BDNF) levels in a neuropsychiatric syndrome of systemic lupus erythematosus patient with organic brain changes
Atsuko Ikenouchi-Sugita, Reiji Yoshimura, Nobuhisa Ueda, et al.
Page
of 30